Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom

Introduction Risks of low-dose aspirin-associated upper and lower gastrointestinal bleeds (UGIB/LGIB) may vary by severity and presence of cardiovascular disease (CVD). No study has quantified these risks for UGIB and LGIB in the same real-world study population.Patients and methods Using UK primary...

Full description

Bibliographic Details
Main Authors: Luis A. García Rodríguez, Angel Lanas, Montse Soriano-Gabarró, Lucía Cea Soriano
Format: Article
Language:English
Published: Taylor & Francis Group 2019-02-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2019.1591635
_version_ 1811255918679031808
author Luis A. García Rodríguez
Angel Lanas
Montse Soriano-Gabarró
Lucía Cea Soriano
author_facet Luis A. García Rodríguez
Angel Lanas
Montse Soriano-Gabarró
Lucía Cea Soriano
author_sort Luis A. García Rodríguez
collection DOAJ
description Introduction Risks of low-dose aspirin-associated upper and lower gastrointestinal bleeds (UGIB/LGIB) may vary by severity and presence of cardiovascular disease (CVD). No study has quantified these risks for UGIB and LGIB in the same real-world study population.Patients and methods Using UK primary care data, 199,049 new users of low-dose aspirin (75–300 mg/day) and 1:1 matched non-users were followed to identify incident UGIB (N = 1843)/LGIB (N = 2763) cases. Nested case-control analyses compared current low-dose aspirin vs. non-use on UGIB/LGIB risk.Results Adjusted incidence rate ratios (ORs; 95% CIs) were 1.62 (1.42–1.86) for non-fatal UGIB, 1.63 (1.47–1.81) for non-fatal LGIB, 0.77 (0.51–1.16) for fatal UGIB, 1.29 (0.50–3.36) for fatal LGIB. For hospitalizations, adjusted ORs (95% CIs) were 1.55 (1.32–1.81) for UGIB and 1.89 (1.58–2.27) for LGIB; for referred only cases, they were 1.52 (1.26–1.84) for UGIB and 1.54 (1.37–1.73) for LGIB. In primary CVD prevention, adjusted ORs (95% CI) were 1.62 (1.38–1.90) for UGIB and 1.60 (1.42–1.81) for LGIB; in secondary CVD prevention, they were 1.16 (0.89–1.50) for UGIB and 1.67 (1.34–2.09) for LGIB.Conclusion Low-dose aspirin was associated with increased risks of non-fatal but not fatal UGIB/LGIB.Key messageLow-dose aspirin is associated with an increased risks of non-fatal UGIB/LGIB but not fatal UGIB/LGIB.
first_indexed 2024-04-12T17:31:07Z
format Article
id doaj.art-86bb8147416b486f86e25607cd8ce803
institution Directory Open Access Journal
issn 0785-3890
1365-2060
language English
last_indexed 2024-04-12T17:31:07Z
publishDate 2019-02-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj.art-86bb8147416b486f86e25607cd8ce8032022-12-22T03:23:07ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602019-02-0151218219210.1080/07853890.2019.1591635Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United KingdomLuis A. García Rodríguez0Angel Lanas1Montse Soriano-Gabarró2Lucía Cea Soriano3Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, SpainServicio de Aparato Digestivo, Hospital Clínico, University of Zaragoza, IIS Aragón, Zaragoza, SpainEpidemiology, Bayer AG, Berlin, GermanySpanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, SpainIntroduction Risks of low-dose aspirin-associated upper and lower gastrointestinal bleeds (UGIB/LGIB) may vary by severity and presence of cardiovascular disease (CVD). No study has quantified these risks for UGIB and LGIB in the same real-world study population.Patients and methods Using UK primary care data, 199,049 new users of low-dose aspirin (75–300 mg/day) and 1:1 matched non-users were followed to identify incident UGIB (N = 1843)/LGIB (N = 2763) cases. Nested case-control analyses compared current low-dose aspirin vs. non-use on UGIB/LGIB risk.Results Adjusted incidence rate ratios (ORs; 95% CIs) were 1.62 (1.42–1.86) for non-fatal UGIB, 1.63 (1.47–1.81) for non-fatal LGIB, 0.77 (0.51–1.16) for fatal UGIB, 1.29 (0.50–3.36) for fatal LGIB. For hospitalizations, adjusted ORs (95% CIs) were 1.55 (1.32–1.81) for UGIB and 1.89 (1.58–2.27) for LGIB; for referred only cases, they were 1.52 (1.26–1.84) for UGIB and 1.54 (1.37–1.73) for LGIB. In primary CVD prevention, adjusted ORs (95% CI) were 1.62 (1.38–1.90) for UGIB and 1.60 (1.42–1.81) for LGIB; in secondary CVD prevention, they were 1.16 (0.89–1.50) for UGIB and 1.67 (1.34–2.09) for LGIB.Conclusion Low-dose aspirin was associated with increased risks of non-fatal but not fatal UGIB/LGIB.Key messageLow-dose aspirin is associated with an increased risks of non-fatal UGIB/LGIB but not fatal UGIB/LGIB.https://www.tandfonline.com/doi/10.1080/07853890.2019.1591635Upper gastrointestinal bleedinglower gastrointestinal bleedingaspirin
spellingShingle Luis A. García Rodríguez
Angel Lanas
Montse Soriano-Gabarró
Lucía Cea Soriano
Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom
Annals of Medicine
Upper gastrointestinal bleeding
lower gastrointestinal bleeding
aspirin
title Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom
title_full Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom
title_fullStr Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom
title_full_unstemmed Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom
title_short Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom
title_sort low dose aspirin and risk of upper lower gastrointestinal bleeding by bleed severity a cohort study with nested case control analysis using primary care electronic health records from the united kingdom
topic Upper gastrointestinal bleeding
lower gastrointestinal bleeding
aspirin
url https://www.tandfonline.com/doi/10.1080/07853890.2019.1591635
work_keys_str_mv AT luisagarciarodriguez lowdoseaspirinandriskofupperlowergastrointestinalbleedingbybleedseverityacohortstudywithnestedcasecontrolanalysisusingprimarycareelectronichealthrecordsfromtheunitedkingdom
AT angellanas lowdoseaspirinandriskofupperlowergastrointestinalbleedingbybleedseverityacohortstudywithnestedcasecontrolanalysisusingprimarycareelectronichealthrecordsfromtheunitedkingdom
AT montsesorianogabarro lowdoseaspirinandriskofupperlowergastrointestinalbleedingbybleedseverityacohortstudywithnestedcasecontrolanalysisusingprimarycareelectronichealthrecordsfromtheunitedkingdom
AT luciaceasoriano lowdoseaspirinandriskofupperlowergastrointestinalbleedingbybleedseverityacohortstudywithnestedcasecontrolanalysisusingprimarycareelectronichealthrecordsfromtheunitedkingdom